BG104240A - Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol - Google Patents
Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterolInfo
- Publication number
- BG104240A BG104240A BG104240A BG10424000A BG104240A BG 104240 A BG104240 A BG 104240A BG 104240 A BG104240 A BG 104240A BG 10424000 A BG10424000 A BG 10424000A BG 104240 A BG104240 A BG 104240A
- Authority
- BG
- Bulgaria
- Prior art keywords
- salmeterol
- compositions
- methods
- optically pure
- treating pulmonary
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- GIIZNNXWQWCKIB-RUZDIDTESA-N (S)-salmeterol Chemical compound C1=C(O)C(CO)=CC([C@H](O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-RUZDIDTESA-N 0.000 title 1
- 208000019693 Lung disease Diseases 0.000 title 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 abstract 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229960004017 salmeterol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/931,636 US6254882B1 (en) | 1997-09-16 | 1997-09-16 | Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol |
| PCT/US1998/018845 WO1999013867A1 (fr) | 1997-09-16 | 1998-09-10 | Compositions de traitement de troubles pulmonaires a base de (s)-salmeterol optiquement pur et methodes correspondantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104240A true BG104240A (en) | 2001-04-30 |
Family
ID=25461118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104240A BG104240A (en) | 1997-09-16 | 2000-03-14 | Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6254882B1 (fr) |
| EP (1) | EP1007008B1 (fr) |
| JP (1) | JP2001516715A (fr) |
| KR (1) | KR20010030610A (fr) |
| CN (1) | CN1270515A (fr) |
| AT (1) | ATE268166T1 (fr) |
| AU (1) | AU754275B2 (fr) |
| BG (1) | BG104240A (fr) |
| BR (1) | BR9812643A (fr) |
| CA (1) | CA2304265A1 (fr) |
| CZ (1) | CZ290394B6 (fr) |
| DE (1) | DE69824296T2 (fr) |
| ES (1) | ES2221991T3 (fr) |
| HU (1) | HUP0003488A3 (fr) |
| IL (1) | IL135022A0 (fr) |
| NO (1) | NO20001343D0 (fr) |
| NZ (1) | NZ503563A (fr) |
| SK (1) | SK3722000A3 (fr) |
| WO (1) | WO1999013867A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
| EP1212089B1 (fr) * | 1999-08-21 | 2006-03-22 | ALTANA Pharma AG | Combinaison synergetique de roflumilast et salmeterol |
| GB9924992D0 (en) * | 1999-10-21 | 1999-12-22 | Glaxo Group Ltd | Pharmaceutical aerosol formulations |
| DE60017450T2 (de) * | 1999-11-23 | 2006-03-02 | Glaxo Group Ltd., Greenford | Pharmazeutische formulierungen enthaltend salmeterol |
| WO2003024396A2 (fr) | 2001-09-17 | 2003-03-27 | Glaxo Group Limited | Formulations de medicament en poudre seche |
| DE60302454T2 (de) * | 2002-04-19 | 2006-08-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Beta-agonisten-verbindungen mit stickoxid-donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen |
| US20060247216A1 (en) * | 2002-10-25 | 2006-11-02 | Haj-Yehia Abdullah I | Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
| AU2004240629B2 (en) * | 2003-05-16 | 2010-02-25 | Arriva Pharmaceuticals, Inc. | Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors |
| JPWO2004112791A1 (ja) * | 2003-06-23 | 2006-07-27 | 協和醗酵工業株式会社 | 肺疾患の治療および/または予防剤 |
| US8426475B2 (en) | 2005-04-13 | 2013-04-23 | Astion Development A/S | Treatment of connective tissue diseases of the skin |
| US8415390B2 (en) | 2008-05-30 | 2013-04-09 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
| US9119777B2 (en) | 2008-05-30 | 2015-09-01 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW6584A1 (en) | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| NZ235605A (en) | 1989-10-10 | 1992-12-23 | Glaxo Group Ltd | (r)-(-)-4-hydroxy-alpha 1 -(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol and pharmaceutical compositions |
| GB9024366D0 (en) | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
| GB9026005D0 (en) | 1990-11-29 | 1991-01-16 | Glaxo Group Ltd | Drug material suitable for micronisation |
| GB9107196D0 (en) * | 1991-04-05 | 1991-05-22 | Sandoz Ag | Improvements in or relating to organic compounds |
| CA2286913C (fr) * | 1997-04-30 | 2008-12-09 | Bridge Pharma, Inc. | Composition et procedes employant un eutomere |
-
1997
- 1997-09-16 US US08/931,636 patent/US6254882B1/en not_active Expired - Fee Related
-
1998
- 1998-09-10 WO PCT/US1998/018845 patent/WO1999013867A1/fr not_active Ceased
- 1998-09-10 IL IL13502298A patent/IL135022A0/xx unknown
- 1998-09-10 JP JP2000511490A patent/JP2001516715A/ja not_active Withdrawn
- 1998-09-10 ES ES98944834T patent/ES2221991T3/es not_active Expired - Lifetime
- 1998-09-10 HU HU0003488A patent/HUP0003488A3/hu unknown
- 1998-09-10 SK SK372-2000A patent/SK3722000A3/sk unknown
- 1998-09-10 KR KR1020007002801A patent/KR20010030610A/ko not_active Abandoned
- 1998-09-10 AT AT98944834T patent/ATE268166T1/de not_active IP Right Cessation
- 1998-09-10 CA CA002304265A patent/CA2304265A1/fr not_active Abandoned
- 1998-09-10 DE DE69824296T patent/DE69824296T2/de not_active Expired - Fee Related
- 1998-09-10 AU AU92283/98A patent/AU754275B2/en not_active Ceased
- 1998-09-10 CZ CZ2000916A patent/CZ290394B6/cs not_active IP Right Cessation
- 1998-09-10 EP EP98944834A patent/EP1007008B1/fr not_active Expired - Lifetime
- 1998-09-10 NZ NZ503563A patent/NZ503563A/en unknown
- 1998-09-10 CN CN98809163A patent/CN1270515A/zh active Pending
- 1998-09-10 BR BR9812643-1A patent/BR9812643A/pt not_active IP Right Cessation
-
2000
- 2000-03-14 BG BG104240A patent/BG104240A/xx unknown
- 2000-03-15 NO NO20001343A patent/NO20001343D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20001343L (no) | 2000-03-15 |
| HUP0003488A3 (en) | 2003-05-28 |
| IL135022A0 (en) | 2001-05-20 |
| CZ2000916A3 (cs) | 2000-08-16 |
| EP1007008A1 (fr) | 2000-06-14 |
| CN1270515A (zh) | 2000-10-18 |
| HUP0003488A2 (hu) | 2001-02-28 |
| ES2221991T3 (es) | 2005-01-16 |
| EP1007008A4 (fr) | 2002-06-12 |
| ATE268166T1 (de) | 2004-06-15 |
| SK3722000A3 (en) | 2000-07-11 |
| US6254882B1 (en) | 2001-07-03 |
| JP2001516715A (ja) | 2001-10-02 |
| NZ503563A (en) | 2002-07-26 |
| NO20001343D0 (no) | 2000-03-15 |
| DE69824296T2 (de) | 2005-06-30 |
| WO1999013867A1 (fr) | 1999-03-25 |
| CZ290394B6 (cs) | 2002-07-17 |
| DE69824296D1 (de) | 2004-07-08 |
| CA2304265A1 (fr) | 1999-03-25 |
| AU9228398A (en) | 1999-04-05 |
| EP1007008B1 (fr) | 2004-06-02 |
| KR20010030610A (ko) | 2001-04-16 |
| BR9812643A (pt) | 2000-08-22 |
| AU754275B2 (en) | 2002-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU681198B2 (en) | Preparation of 3,4,4-trisubstituted-piperidinyl-N- alkylcarboxylates and intermediates | |
| BG104240A (en) | Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol | |
| CA2245768A1 (fr) | Procedes pour le traitement du vomissement et les troubles du systeme nerveux central au moyen de norcisapride (+) optiquement pur | |
| DE59501599D1 (de) | Verfahren zur Herstellung von Propandiol-1,2 | |
| ITVI930163A0 (it) | Metodo per la realizzazione di supporti elestici integralli, nonche'supporti con esso ottenuti | |
| IL122012A0 (en) | Process for the separation of a mixture of enantiomers | |
| AU7174191A (en) | Optically pure r(-) albuterol for treating asthma | |
| AU1315795A (en) | Process for the preparation of an optically pure enantiomer of formoterol | |
| DK0787715T3 (da) | Fremgangsmåde til racematspaltning af tramadol | |
| IT9019331A1 (it) | Procedimento per la preparazione di levo e destro fenfluramina | |
| ATE238271T1 (de) | Desformoterol und verfahren zu seiner herstellung | |
| PT938584E (pt) | Processo para o fabrico do ácido (s)-3,3,3-trifluoro-2-hidroxi-2-metilpropiónico ou (r)-3,3,3-trifluoro-2-hidroxi-2-metilpropiónico | |
| EP0968997A3 (fr) | Procédé pour la préparation de la S-Aryl-L-cystéine et dérivés | |
| FR2719998B1 (fr) | Composition immunisante anti-hélicobacter pylori à base de catalase. | |
| BR9103481A (pt) | Composto,estereoisomero,composicao farmaceutica e processo para preparar um composto | |
| ATE339423T1 (de) | Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält | |
| DE69802329D1 (de) | Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen | |
| WO2000010544A3 (fr) | Procede prevenant l'apparition de l'asthme | |
| EP1236715A3 (fr) | Procédé pour la préparation de la S-aryl cystéine | |
| AU755526C (en) | 1-(4-arylpiperazin-1-YL)-3-(2-oxopyrrolidin/piperidin-1-YL) propanes used as potential therapeutic agents for hypertension, ischemia, cardiovascular and other adrenergic receptors related disorders, a process for preparing such compounds and a method of treating above diseases using the compounds | |
| AU7236494A (en) | New method for n-cyclopropylation of aromatic amines, as well as compounds and compositions obtained | |
| UA28664A (uk) | Спосіб приготування горілки "карат" |